from development to disease
The 2017 Champalimaud Research Symposium, with the theme “Physiology: from development to disease” will be held in Lisbon, Portugal from the 9th to the 11th of October 2017. The Symposium will be a single-track scientific meeting with 14 invited speakers. It will focus on modern physiology in development, aging, immunity and cancer, bridging cutting edge biology research with disease oriented research, and will feature a keynote lecture from Professor Bob Horvitz, winner of the 2002 Prize in Physiology or Medicine, shared with Sydney Brenner and John Sulston, “for their discoveries concerning genetic regulation of organ development and programmed cell death”.
This Symposium is a very special event as it will serve as the inaugural conference to launch the Champalimaud Biology of Systems and Metastasis Research Program. This new research program, together with the neuroscience program, aims at establishing the Champalimaud Centre for the Unknown as a premier biomedical research effort. After five successful neuroscience symposia, it is a great pleasure to commence this new phase of the Champalimaud Research with what promises to be this exciting and rewarding Symposium. The diverse list of distinguished speakers shown below will reflect the vision for our research.
The Symposium will be held at our Centre on the stunning waterfront in Lisbon, and will also feature a social programme which will give participants the chance to explore this beautiful and historic city. We expect that the unique venue, together with the exciting list of invited speakers, will foster a lively and stimulating scientific meeting.
Caetano Reis e Sousa
ORGANISERS AND TECHNICAL SUPPORT
Anna Hobbiss, Ana Casaca, Gil Costa, Catarina Ramos
Meet our SpeakersThey are focused on modern physiology in development, aging, immunity and cancer, bridging cutting edge biology research with disease oriented research
Inaugurated on October 5th 2010, the Champalimaud Centre for the Unknown is now a part of the important riverside area of Belém, near the magnificent Tower of Belém. This area, where the river Tejo meets the Atlantic Ocean, is of great historical significance as the great Portuguese pioneers sailed from this location to discover the “unknown” in the XV and XVI centuries.
The presence of the Champalimaud Centre for the Unknown leverages this historical heritage by creating an inspirational link between the discoveries of yesteryear and the epic adventure of scientific research. Here, everything converges in the creation of a unique atmosphere for the development of the most advanced multidisciplinary and translational research in the field of biomedicine. The building’s contemporary architecture, along with its functionality, offers outstanding conditions to investigators, academics and health professionals, from Portugal and beyond, to carry out work oriented towards excellence and practical results.
The Champalimaud Centre for the Unknown covers an area of 60,000m2 facing the river Tejo and comprises three large areas. The main building houses the Champalimaud Clinical Centre’s diagnostic and treatment facilities, an indoor garden, research laboratories and administrative services, all interlinked to promote discussion and collaboration between scientists, clinicians and other professionals. A tropical pergola-covered garden is at the heart of this structure.
The Champalimaud Centre for the Unknown is a state-of-the-art facility for science, medicine, technology and public use.
Champalimaud Centre for the Unknown
Media and Publishing partner
Cells (ISSN 2073-4409, PubMed/PMC indexed) is an international open access journal of cell biology, molecular biology, and biophysics, which is published quarterly by MDPI AG, Basel, Switzerland. Manuscripts regarding original research and ideas will be particularly welcomed. We also accept reviews, conference papers, communications, short notes and case reports.
Cells maintains rigorous peer-review and a rapid publication process. Research articles, reviews, and other contents are released on the Internet immediately after acceptance.
The Company of Biologists is a not-for-profit publishing organisation dedicated to supporting and inspiring the biological community.
We are run by distinguished practicing scientists. We exist to profit science, not shareholders. We inspire new thinking and support the worldwide community of biologists.
We do this by publishing leading peer-reviewed journals, facilitating scientific meetings and communities, providing travel grants for young researchers and by supporting societies and gatherings.
For more information visit www.biologists.com
Linde Healthcare is a global business unit of The Linde Group. It is present in over 60 countries, and has been extensively involved in the development of therapies and diagnostic procedures, where gases, gas technology or gas competence is needed. In surgeries, emergency services, intensive care, clinics and Investigation Centres, the company offers a broad spectrum of products and services to effectively support medical practitioners and their patients. Linde Healthcare co-operates with researchers in hospitals and universities as well as a global network of physicians, clinicians and technicians working on the frontlines.
UCB is a global biopharmaceutical company, with a focus on neurology and immunology.
Our business is strong. Total revenue grew to €4.2 billion in 2016. We are more than 7,700 people in all four corners of the globe, inspired by patients and driven by science.
Looking ahead, we have a solid platform for continuous growth with our core products Cimzia®, Vimpat®, Neupro®, Keppra® and Briviact®, and we are preparing the launch of a potential medicine to help patients with osteoporosis. At the same time, we are very excited about the progress in our early research pipeline.
For more information go to https://www.ucb.com
Good health makes life better. Wellcome Trust wants to improve health for everyone by helping great ideas to thrive.
That’s why we support thousands of curious, passionate people all over the world to explore great ideas, at every step of the way from discovery to impact.
We also identify priority areas where we can give focused, intensive support when there are real opportunities to transform lives, or we can drive reform to ensure that ideas reach their full potential
For more information visit: https://wellcome.ac.uk/
The Ultragene project was created in 2008 with the objective of having commercialization, installation and technical assistance of equipment and products for biomedical research, with special focus on research and experimentation with laboratory animals. For this we have a team and partners with expertise in this area, as well as in support of design, engineering, planning and construction of turnkey integrated solutions.
For more information visit: ultragene.pt
Filsat is a company that sells Medical, Scientific and Industrial equipment, recognized in the international market, guaranteeing its installation, the training of users and the subsequent technical assistance. We operate in Portugal, Spain and in Portuguese-speaking African Countries.
For more information visit: http://www.filsat.pt/
By partnering with the 2017 Champalimaud Research Symposium, your organisation will be associated with one of the key scientific international events held in Portugal and engage with the national and international scientific community dedicated to disease oriented research, with a special focus on modern physiology in development, ageing, immunity and cancer.
We will be delighted to discuss these packages as well as any additional partnership ideas you would like to suggest, in order to have your organisation on-board! Please contact us for further information.